Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid

Patrick H Dessein1, Barry I Joffe, Martin G Veller

  • 1Department of Rheumatology, Johannesburg Hospital, Johannesburg, South Africa. Dessein@lancet.co.za

Insights

Cardiovascular risk factors like age and hypertension, alongside inflammation and disease severity in rheumatoid arthritis (RA), are linked to atherosclerosis. Standard risk assessments may underestimate cardiovascular disease risk in RA patients.

Area of Science:

  • Rheumatology and Cardiology
  • Vascular Biology and Atherosclerosis

Background:

  • Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular (CV) disease.
  • Understanding the specific risk factors for atherosclerosis in RA patients is crucial for risk stratification and management.

Purpose of the Study:

  • To investigate the association between traditional and nontraditional cardiovascular risk factors and the presence of atherosclerosis in patients with rheumatoid arthritis.

Main Methods:

  • Seventy-four RA patients underwent high-resolution B-mode ultrasound to assess common carotid artery intima-media thickness (IMT) and plaque.
  • Logistic regression, classification and regression tree (CART), and factor analyses were used to evaluate associations between clinical/laboratory variables and atherosclerosis.

Main Results:

  • Atherosclerosis was detected in 72% of patients, with plaque in 31%.
  • Age and hypertension were independently associated with atherosclerosis and plaque.
  • Inflammatory markers (polymorphonuclear cell counts) and cumulative disease burden (radiographic scores) were strongly linked to plaque presence.

Conclusions:

  • Atherosclerosis in RA is influenced by traditional CV risk factors (age, hypertension) and nontraditional factors including inflammation and disease severity.
  • Standard CV risk assessment tools may not fully capture the extent of atherosclerosis risk in RA patients.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...